California
Colorectal cancer biologic therapy trials in California
19 colorectal cancer biologic therapy studies are recruiting participants at sites in 32 cities across California as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Browse California by city
Cities with the most studies recruiting right now.
Los Angeles
13 studies recruiting.
Duarte
6 studies recruiting.
Santa Monica
5 studies recruiting.
Every California city with a recruiting study
Los Angeles (13), Duarte (6), Santa Monica (5), Los Alamitos (3), Sacramento (3), San Francisco (3), Santa Rosa (3), Bakersfield (2), Glendale (2), Irvine (2), Newport Beach (2), Torrance (2), Berkeley (1), Corona (1), Costa Mesa (1), Encinitas (1), Fountain Valley (1), Fremont (1), Fullerton (1), Huntington Beach (1), La Jolla (1), Long Beach (1), Orange (1), Palo Alto (1), Roseville (1), San Diego (1), San Mateo (1), South Pasadena (1), Sunnyvale (1), Upland (1), Vista (1), Whittier (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in California
Basic details from each study's public record (the 12 most recently updated of 19). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Fountain Valley · Los Angeles · Sacramento · and 1 more U.S. location
- Registry record
- NCT06997497 · updated
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Costa Mesa · Irvine · Los Angeles · and 1 more U.S. location
- Registry record
- NCT06102902 · updated
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Recruiting in
- Los Angeles
- Registry record
- NCT05379595 · updated
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Recruiting in
- Bakersfield · Glendale · Los Alamitos · and 4 more U.S. locations
- Registry record
- NCT06662786 · updated
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Recruiting in
- Bakersfield · Glendale · Los Alamitos · and 4 more U.S. locations
- Registry record
- NCT06750094 · updated
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Los Angeles
- Registry record
- NCT06428409 · updated
A Study of MGC026 in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- MacroGenics
- Recruiting in
- Los Angeles
- Registry record
- NCT06242470 · updated
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- GlaxoSmithKline
- Recruiting in
- Los Alamitos · Los Angeles · Santa Monica · and 1 more U.S. location
- Registry record
- NCT06885034 · updated
Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- City of Hope Medical Center
- Recruiting in
- Corona · Duarte · Huntington Beach · and 4 more U.S. locations
- Registry record
- NCT07595874 · updated
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Recruiting in
- Berkeley · Encinitas · Fremont · and 10 more U.S. locations
- Registry record
- NCT07222800 · updated
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Dispatch Biotherapeutics
- Recruiting in
- Duarte · Newport Beach
- Registry record
- NCT07544589 · updated
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Duarte · Los Angeles · Newport Beach · and 1 more U.S. location
- Registry record
- NCT05877599 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in California on ClinicalTrials.gov.
Ask about studies in California
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.
Colorectal Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections